FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for fenofibrate from Cipla USA Inc. The approval indicates an update or addition via a supplemental filing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

SUPPL AP for FENOFIBRATE (FENOFIBRATE)